BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 19, 2008
View Archived Issues
Recent GSK patent reports novel treatment options for renal disorders
Read More
Preclinical, clinical studies describe activity, tolerability, pharmacokinetics of AMG-317
Read More
MEDI-563 mechanism, biological activity reported
Read More
Mometasone increases days with minimal symptoms in rhinosinusitis patients
Read More
Rapid symptom relief seen with icatibant in hereditary angioedema attacks
Read More
Archemix initiates phase II trial in thrombotic thrombocytopenic purpura
Read More
Millennium adds new IBD development candidate to its pipeline
Read More
Targacept initiates phase I trial of TC-5214 in major depressive disorder
Read More
Recent patents disclose new anticancer agents
Read More
Valeant reports encouraging phase IIb results at week 12 for taribavirin
Read More
Akesis provides preliminary data from AKP-020 phase IIa type 2 diabetes trial
Read More
Vasogen prepares response to FDA regarding ACCLAIM II clinical trial of Celacade
Read More
Ipsen submits BLA to the FDA for Reloxin in aesthetic indications
Read More
Merrimack completes enrollment in phase II trial of MM-093 in rheumatoid arthritis
Read More
BioCancell initiates treatment in phase IIb clinical trial of BC-819 for superficial bladder cancer
Read More
Astellas receives approvable letter for NDA for once-daily tacrolimus in kidney transplants
Read More
Novel beta-glucuronidase analogue shows promise in murine mucopolysaccharidosis VII
Read More
Nerve growth factor mimetic peptide effective in rat neuropathic pain model
Read More
Omrix receives FDA approval to initiate phase II clinical trial of fibrin patch product
Read More
FDA does not grant approval for Genta's Genasense in chronic lymphocytic leukemia
Read More
DSMB recommends continuation of Arena's phase III BLOOM trial of lorcaserin in obesity
Read More
Nisshin Kyorin receives approval for ulcerative colitis agent Pentasa
Read More
Milatuzumab receives FDA orphan drug designation for multiple myeloma
Read More